GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 651 - 675 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgA Patient 4 12 mild
G17266GE
634
IgA Patient 2 24 mild
G78255UI
633
IgM Patient 4 12 mild
G91537AT
633
IgG Patient 2 3 mild
G96557TJ
632
IgA Patient 1 22 moderate
G25559RS
630
IgA Patient 2 24 mild
G11460AB
630
IgG Patient 2 3 mild
G30839DN
628
IgM Patient 2 15 mild
G11460AB
626
IgA Patient 2 3 mild
G77974XY
626
IgA Patient 4 12 mild
G42666HT
626
IgM Patient 3 -180 mild
G47362BJ
625
IgM Patient 4 12 mild
G32699RJ
625
IgA Patient 1 6 moderate
G15407YE
624
IgA Patient 2 3 mild
G58969RU
623
IgM Patient 2 3 mild
G36544AC
623
IgA Patient 3 11 mild
G82096UQ
621
IgA Patient 4 12 mild
G14988WV
621
IgG Patient 2 15 mild
G48898TH
620
IgA Patient 2 24 mild
G82779CI
619
IgA Patient 3 -180 mild
G64669AQ
617
IgA Patient 4 12 mild
G51872EK
616
IgA Patient 1 22 moderate
G47362BJ
613
IgG Patient 2 24 mild
G72739GY
613
IgA Patient 2 3 mild
G78255UI
613
IgA Patient 1 10 moderate
G25559RS
612

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024